GB1519208A - Therapeutic products - Google Patents

Therapeutic products

Info

Publication number
GB1519208A
GB1519208A GB50398/75A GB5039875A GB1519208A GB 1519208 A GB1519208 A GB 1519208A GB 50398/75 A GB50398/75 A GB 50398/75A GB 5039875 A GB5039875 A GB 5039875A GB 1519208 A GB1519208 A GB 1519208A
Authority
GB
United Kingdom
Prior art keywords
plasma
factor
viii
dec
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB50398/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Serum Institut GmbH
Original Assignee
Biotest Serum Institut GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut GmbH filed Critical Biotest Serum Institut GmbH
Publication of GB1519208A publication Critical patent/GB1519208A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB50398/75A 1974-12-14 1975-12-09 Therapeutic products Expired GB1519208A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2459291A DE2459291C3 (de) 1974-12-14 1974-12-14 Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen

Publications (1)

Publication Number Publication Date
GB1519208A true GB1519208A (en) 1978-07-26

Family

ID=5933473

Family Applications (1)

Application Number Title Priority Date Filing Date
GB50398/75A Expired GB1519208A (en) 1974-12-14 1975-12-09 Therapeutic products

Country Status (8)

Country Link
US (1) US4081431A (https=)
JP (1) JPS5182716A (https=)
AT (1) AT343277B (https=)
BE (1) BE836193A (https=)
DE (1) DE2459291C3 (https=)
FR (1) FR2293943A1 (https=)
GB (1) GB1519208A (https=)
NL (1) NL7514338A (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4302445A (en) * 1980-01-18 1981-11-24 Institut Merieux Method for concentrating and purifying antihemophilic factor or factor VIII
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4473647A (en) * 1981-02-27 1984-09-25 Amf Inc. Tissue culture medium
EP0081482A1 (en) * 1981-06-18 1983-06-22 E. G. Birger Blombäck A process in purification and concentration of the factor viii complex
EP0076870B1 (en) * 1981-10-12 1985-06-05 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor
DE3247150A1 (de) * 1982-12-21 1984-06-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems
FR2573997B1 (fr) * 1984-12-03 1986-12-26 Commissariat Energie Atomique Support solide capable d'adsorber des lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que le plasma sanguin
JPS6317899A (ja) * 1986-07-09 1988-01-25 Green Cross Corp:The ハプトグロビンの精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
US4963265A (en) * 1988-05-06 1990-10-16 Applied Immunesciences, Inc. Plasma processing device with anaphylatoxin remover
WO1992015670A1 (en) * 1991-02-28 1992-09-17 Hyclone Laboratories, Inc. Blended bovine sera cellular growth media and their methods of production and use
DE69826531T2 (de) * 1998-06-23 2005-09-22 Shanbrom Technologies, LLC, Ojai Verfahren und vorrichtung zur herstellung von gereinigten plasmaproteinen
US8597471B2 (en) 2010-08-19 2013-12-03 Industrial Idea Partners, Inc. Heat driven concentrator with alternate condensers
AU2014262532B2 (en) 2013-05-09 2019-08-22 Advanced Neuroregenerative Therapies, Llc G-CSF for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor

Also Published As

Publication number Publication date
ATA939375A (de) 1977-09-15
NL7514338A (nl) 1976-06-16
FR2293943A1 (fr) 1976-07-09
DE2459291C3 (de) 1981-06-04
JPS5516487B2 (https=) 1980-05-02
DE2459291A1 (de) 1976-06-16
US4081431A (en) 1978-03-28
DE2459291B2 (de) 1979-03-15
BE836193A (fr) 1976-04-01
FR2293943B1 (https=) 1979-01-19
AT343277B (de) 1978-05-26
JPS5182716A (en) 1976-07-20

Similar Documents

Publication Publication Date Title
GB1519208A (en) Therapeutic products
Owen et al. The conversion of prothrombin to thrombin: I. Characterization of the reaction products formed during the activation of bovine prothrombin
Mammen et al. Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A)
Porter Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites
AU563925B2 (en) Removal of lipid containing virus in blood
Klein et al. The nature of plasma antithrombin activity
IE42466L (en) Peptide derivatives of phosphonic and phosphinic acids.
Lwebuga-Mukasa et al. Collagenase enzymes from Clostridium: characterization of individual enzymes
GB1303408A (https=)
GB1441751A (en) Purification of albumin by thermocoagulation
Marder et al. The purification of fibrinogen degradation products by Pevikon block electrophoresis
Li et al. Purification and properties of rat prothrombin
Colman et al. [12] Factor V
Davison Chromatography of histones
US3234106A (en) Soluble, purified profibrinolysin and fibrinolysin and method of producing same
US3434929A (en) Process for purifying plasmin
Liu et al. Tissue extract thromboplastin: Quantitation, fractionation and characterization of protein components
Arnesen et al. Studies on the thrombin clotting time: I. The influence of fibrinogen degradation products
Hayashi et al. Yeast Pro-proteinase C Part II. Isolation and Some Physicochemical Properties
Harris et al. The carboxymethylation of human metmyoglobin
Ewald et al. Δ5-3-ketosteroid isomerase: Solubilization and stabilization in beef adrenal gland preparations
Fantl et al. Fibrinolysis induced by brain extracts
Tsuboi et al. Enzymes of the human erythrocyte. III. Tripeptidase, purification and specific properties
GB1222810A (en) Prothrombin complex
GB1471006A (en) Preparation of albumin

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee